Return On Assets of Intra-Cellular Therapies, Inc. from 31 Dec 2013 to 31 Dec 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Intra-Cellular Therapies, Inc. quarterly and annual Return On Assets in % history and change rate from 31 Dec 2013 to 31 Dec 2024.
  • Intra-Cellular Therapies, Inc. Return On Assets for the quarter ending 31 Dec 2024 was -6%, a 68% increase year-over-year.
  • Intra-Cellular Therapies, Inc. annual Return On Assets for 2024 was -6%, a 68% increase from 2023.
  • Intra-Cellular Therapies, Inc. annual Return On Assets for 2023 was -19%, a 39% increase from 2022.
  • Intra-Cellular Therapies, Inc. annual Return On Assets for 2022 was -32%, a 34% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Intra-Cellular Therapies, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2024 -6% +13% +68% 01 Oct 2024 31 Dec 2024
Q3 2024 -8% +13% +61% 01 Jul 2024 30 Sep 2024
Q2 2024 -10% +15% +61% 01 Apr 2024 30 Jun 2024
Q1 2024 -15% +14% +49% 01 Jan 2024 31 Mar 2024
Q4 2023 -19% +12% +39% 01 Oct 2023 31 Dec 2023
Q3 2023 -21% +19% +47% 01 Jul 2023 30 Sep 2023
Q2 2023 -25% +22% +47% 01 Apr 2023 30 Jun 2023
Q1 2023 -30% +18% +38% 01 Jan 2023 31 Mar 2023
Q4 2022 -32% +17% +34% 01 Oct 2022 31 Dec 2022
Q3 2022 -40% 0% -0.27% 01 Jul 2022 30 Sep 2022
Q2 2022 -47% -13% -38% 01 Apr 2022 30 Jun 2022
Q1 2022 -48% -12% -34% 01 Jan 2022 31 Mar 2022
Q4 2021 -48% -11% -29% 01 Oct 2021 31 Dec 2021
Q3 2021 -40% +2% +5.4% 01 Jul 2021 30 Sep 2021
Q2 2021 -34% +17% +34% 01 Apr 2021 30 Jun 2021
Q1 2021 -36% +13% +26% 01 Jan 2021 31 Mar 2021
Q4 2020 -38% +12% +24% 01 Oct 2020 31 Dec 2020
Q3 2020 -43% +3% +7.2% 01 Jul 2020 30 Sep 2020
Q2 2020 -51% -7% -16% 01 Apr 2020 30 Jun 2020
Q1 2020 -48% -7% -18% 01 Jan 2020 31 Mar 2020
Q4 2019 -50% -11% -29% 01 Oct 2019 31 Dec 2019
Q3 2019 -46% -12% -36% 01 Jul 2019 30 Sep 2019
Q2 2019 -44% -14% -46% 01 Apr 2019 30 Jun 2019
Q1 2019 -41% -15% -55% 01 Jan 2019 31 Mar 2019
Q4 2018 -39% -13% -51% 01 Oct 2018 31 Dec 2018
Q3 2018 -34% -7% -28% 01 Jul 2018 30 Sep 2018
Q2 2018 -30% -6% -22% 01 Apr 2018 30 Jun 2018
Q1 2018 -27% 0% -0.68% 01 Jan 2018 31 Mar 2018
Q4 2017 -26% 0% -1.3% 01 Oct 2017 31 Dec 2017
Q3 2017 -26% -2% -8.2% 01 Jul 2017 30 Sep 2017
Q2 2017 -25% 0% +1.2% 01 Apr 2017 30 Jun 2017
Q1 2017 -26% 0% -0.08% 01 Jan 2017 31 Mar 2017
Q4 2016 -25% +4% +13% 01 Oct 2016 31 Dec 2016
Q3 2016 -24% +9% +27% 01 Jul 2016 30 Sep 2016
Q2 2016 -25% +11% +31% 01 Apr 2016 30 Jun 2016
Q1 2016 -26% +4% +12% 01 Jan 2016 31 Mar 2016
Q4 2015 -29% -7% -31% 01 Oct 2015 31 Dec 2015
Q3 2015 -33% -13% -64% 01 Jul 2015 30 Sep 2015
Q2 2015 -36% -13% -54% 01 Apr 2015 30 Jun 2015
Q1 2015 -30% +14% +33% 01 Jan 2015 31 Mar 2015
Q4 2014 -22% +103% +82% 01 Oct 2014 31 Dec 2014
Q3 2014 -20% 01 Jul 2014 30 Sep 2014
Q2 2014 -24% 01 Apr 2014 30 Jun 2014
Q1 2014 -44% 01 Jan 2014 31 Mar 2014
Q4 2013 -125% 01 Oct 2013 31 Dec 2013

Intra-Cellular Therapies, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -6% +13% +68% 01 Jan 2024 31 Dec 2024
2023 -19% +12% +39% 01 Jan 2023 31 Dec 2023
2022 -32% +17% +34% 01 Jan 2022 31 Dec 2022
2021 -48% -11% -29% 01 Jan 2021 31 Dec 2021
2020 -38% +12% +24% 01 Jan 2020 31 Dec 2020
2019 -50% -11% -29% 01 Jan 2019 31 Dec 2019
2018 -39% -13% -51% 01 Jan 2018 31 Dec 2018
2017 -26% 0% -1.3% 01 Jan 2017 31 Dec 2017
2016 -25% +4% +13% 01 Jan 2016 31 Dec 2016
2015 -29% -7% -31% 01 Jan 2015 31 Dec 2015
2014 -22% +103% +82% 01 Jan 2014 31 Dec 2014
2013 -125% 01 Jan 2013 31 Dec 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.